Monopar Therapeutics Closes $19.2 Million Stock Offering

Monopar Therapeutics Inc ( (MNPR) ) just unveiled an announcement.

Monopar Therapeutics Inc., a biotech firm focused on innovative treatments, successfully closed a public offering of its common stock, raising approximately $19.2 million. The offering, priced at $16.25 per share, saw participation from notable investors, including Janus Henderson Investors and RA Capital Management. Rodman & Renshaw LLC acted as the exclusive placement agent. Monopar plans to use the proceeds for general corporate purposes such as research and development and clinical trials.

For an in-depth examination of MNPR stock, go to TipRanks’ Stock Analysis page.